Phase 1/2 , An Open-Label Safety Study of Single-dose VGR-R01 in Patients With Bietti Crystalline Dystrophy

Study Details | Safety and Tolerability of VGR-R01 in Patients With Bietti Crystalline Dystrophy | ClinicalTrials.gov

A Multi-Center, Randomized, Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of VGR-R01 in Subjects with Bietti Crystalline Dystrophy

Study Details | Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients with Bietti Crystalline Dystrophy | ClinicalTrials.gov

An Open, Dose-escalating and Dose Confirmation Trial to Evaluate the Safety and Efficacy of VGN-R09b by Intra Putamen Injection in Patients With Severe Aromatic L-amino Acid Decarboxylase (AADC) Deficiency

Study Details | A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency | ClinicalTrials.gov

A Phase Ⅰb/Ⅱ Study to Evaluate the Tolerability, Safety, and Efficacy of VGN-R09b in Patients With Parkinson's Disease

Study Details | A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease | ClinicalTrials.gov

An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease

Study Details | An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease | ClinicalTrials.gov

Phase 1/2, An Open-Label, Dose-Escalation and Dose-Expansion Phase I Clinical Study to Evaluate the Tolerability, Safety and Efficacy of VGM-R02b in Patients With Glutaric Acidemia Type I

Study Details | A Study to Evaluate the Tolerability, Safety and Efficacy of VGM-R02b | ClinicalTrials.gov